Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer

BACKGROUND: The incidence of Clostridioides difficile infection (CDI) is reportedly higher and the cure rate lower in individuals with cancer vs those without cancer. An exploratory post hoc analysis of the MODIFY I/II trials (NCT01241552/NCT01513239) investigated how bezlotoxumab affected the rate...

Descripción completa

Detalles Bibliográficos
Autores principales: Cornely, Oliver A, Mullane, Kathleen M, Birch, Thomas, Hazan-Steinberg, Sabine, Nathan, Richard, Bouza, Emilio, Calfee, David P, Ellison, Misoo Chung, Wong, Michael T, Dorr, Mary Beth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029680/
https://www.ncbi.nlm.nih.gov/pubmed/32099847
http://dx.doi.org/10.1093/ofid/ofaa038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029680/
https://www.ncbi.nlm.nih.gov/pubmed/32099847
http://dx.doi.org/10.1093/ofid/ofaa038

Ejemplares similares